CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the presentation, the Company will unveil its new five-year strategy, which will guide the Company's next phase of gro.

For a portion of 2025, municipal bonds scuffled amid concerns about the state of the U.S. economy, a spate of new issuances and lack of clarity from the Federal Reserve on interest rates. Skeptics may assert those issues haven't been fully resolved.

China stocks were among the world's top performers last year. The MSCI China Index jumped 31%, slightly trailing the 34% returned by the MSCI Emerging Markets Index.

Dividend stocks are a favorite among investors for good reason. They provide a steady income stream and offer a promising avenue for total return.

Shares of US oil companies surged on Monday, a jump spurred by the potential to gain access to Venezuela's massive oil reserves. Shares of Chevron, the sole US major currently operating in Venezuela's oil fields, saw a 6.5% jump in premarket trading, according to a Reuters report.

The acquisition, which is subject to closing conditions, would encompass Quantum 's proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction

SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses to contact our firm now.

IRVINE, Calif.--(BUSINESS WIRE)---- $DSP #AI--Viant announced the launch of Outcomes, its first fully autonomous advertising product, bringing to life the AI Decisioning functionality of ViantAI.

Jefferies Financial Group Inc. (NYSE: JEF) will release earnings results for the fourth quarter, after the closing bell on Wednesday, Jan. 7, 2025.

SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026.

KeyBanc analyst Brandon Nispel expects the wireless carrier to beat rivals Verizon and T-Mobile in the race for convergence.

SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Stride, Inc. (NYSE: LRN) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses in LRN to contact Hagens Berman now to discuss their rights.

US indices look to recover on Monday despite military action over the weekend.

Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from a new in-vitro pre-clinical study evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation compared to hydroxypropyl methylcellulose (HPMC), an accepted and standard comparator used in nasal barrier products.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 5, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) ("Stride" or the "Company") on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Stride securities during the Class Period may, no later than January 12, 2026, seek to be appointed as a lead plaintiff representative of the class.

Tesla (TSLA) stock has entered a 7-day losing streak, resulting in total losses of 10% during this timeframe. The company's market capitalization has decreased by approximately $163 billion over the past week and currently sits at $1.4 trillion.

Company leaders to highlight how advanced technology is changing the industrial landscape during keynote and live demonstrations IRVING, Texas, Jan. 5, 2026 /PRNewswire/ -- Caterpillar Inc. (NYSE: CAT) will take the keynote stage and show floor at CES® 2026, the world's most powerful tech event, to highlight how Industrial AI and autonomy are unlocking innovation and transforming worksites around the world. "Caterpillar's legacy of innovation is rooted in solving our customers' toughest challenges, and that mission continues to guide our future," said Caterpillar CEO Joe Creed.

New analog and embedded processing technologies from TI enable automakers to deliver smarter, safer and more connected driving experiences across their entire vehicle fleet News highlights: TI's newest family of high-performance computing SoCs delivers safe, efficient edge AI performance up to 1200 TOPS with a proprietary NPU and chiplet-ready design. Automakers can simplify radar designs and address advanced use cases with TI's eight-by-eight 4D imaging radar transceiver.

Traditional food logging apps offer feedback after the fact—Libre Assist1 offers help in-the-moment to inform mealtime decisions before every bite Libre Assist1 leverages AI to predict how food choices affect glucose levels,2 provides personalized meal guidance,3 and confirms glucose impact using data from Abbott's world-leading FreeStyle Libre continuous glucose monitoring (CGM) technology4 Abbott is launching Libre Assist, available at no additional cost within the Libre app,5 during CES® 2026 ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the millions …

LAS VEGAS--(BUSINESS WIRE)--Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), an IoT and AI-based SaaS company at the forefront of Asset Intelligence technology, today announced the appointment of Dr. Ansgar Thiede as Chief Strategy Officer, effective January 5, 2026. The appointment strengthens Dot Ai's executive leadership team as the company scales its platform, deepens enterprise customer engagement, and builds the operational foundation to support long-term growth. As Chief Strategy Offic.